Ardena announces €20m expansion following first GMP approval

Betsy Goodfellow | April 19, 2024 | News story | Manufacturing and Production Ardena, Pharmacy, facility, manufacturing 

Ardena has announced that it has received Good Manufacturing Practice (GMP) approval from the Dutch Healthcare Authority for its new analytical laboratories in its expanded facility.

The new nanomedicines facility includes ‘state-of-the-art GMP-compliant cleanrooms to support Ardena’s growing nanomedicines business, as well as laboratories for process development and analytical work, GMP production space, and warehouse facilities’, according to the company’s press release.

The new facility spans 2,200m2 and is located near the company’s existing 4,000m2 facilities at Pivot Park, Oss, the Netherlands.

Harry Christiaens, chief executive officer of Ardena, commented: “There is a growing demand for expert nanomedicine services. The €20 million expansion of our advanced nanomedicines facility represents a significant investment for Ardena and underscores our commitment to innovation and excellence in pharmaceutical development. With this expanded capacity, we are well-equipped to advance nanomedicine research and development, accelerate the development and manufacturing of groundbreaking nanomedicine drugs, bring novel therapies from concept to clinic in a timely and efficient manner, and, ultimately, benefit patients worldwide. […] These developments align seamlessly with Ardena’s mission of expertly guiding clients through every stage of drug development with expertise and precision.”

Betsy Goodfellow

Related Content

AbbVie invests €150m in new R&D facility in Germany

AbbVie has announced that it is investing approximately €150m in its second largest research and …

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

Eli Lilly and Nexus Pharmaceuticals have announced that they have entered into a definitive agreement …

Lonza to acquire biologics site in Vacaville, US from Roche for $1.2bn

Lonza has announced that it has signed an agreement to acquire the Genentech large-scale biologics …

Latest content